President Joe Biden is expected to sign an executive order aimed at lowering drug prices; the FDA imposes limits on who should receive a controversial new Alzheimer disease drug; western US states prepare for a second heat wave.
As part of an executive order he is expected to sign today, President Joe Biden will call on federal health officials to increase their efforts to lower prescription drug prices, The Washington Post reports. The measure will prompt federal agencies to promote economic competition and will direct the administration to work with states to create plans for importing medicines from Canada, where they are sold at lower prices. Former President Donald Trump embraced a similar initiative despite objections from pharmaceutical companies, while the plan is largely supported by Democrats.
Following backlash on its broad indication for the newly approved and controversial Alzheimer drug aducanumab (Aduhelm), the FDA yesterday released updated guidance on who should receive the treatment, narrowing down the previous 6 million eligible patients. Reported by The New York Times, only those with mild memory or thinking problems should receive infusions of Aduhelm. In clinical trials supporting the drug's approval, the treatment was only administered to this patient population, which is why many experts reacted with surprise when the initial approval was for all patients, regardless of disease stage.
After a deadly heat wave recently struck the Northwest region of the United States and parts of Canada, states are again bracing for another spike in temperatures. This next wave is not expected to be as high as the previous one, but temperatures are expected to be 25 degrees above average for this time of year, according to The Washington Post. In California, an excessive heat warning is in place for the weekend, while temperatures are expected to reach the triple digits for the state’s inland regions. New data also show the death toll from the previous heat wave has increased to 78 in Washington state. In comparison, the state saw just 39 heat-related deaths between 2015 and 2020.
Bridging the Vaccination Gap: Insights on Global Immunization Challenges
July 30th 2024On this episode of Managed Care Cast, we speak with Jeffery A. Goad, PharmD, MPH, 2024-2025 president of the National Foundation for Infectious Diseases, on the recent report from the World Health Organization and UNICEF on public immunization rates, with national and global health implications.
Listen
Despite Record ACA Enrollment, Report Reveals Underinsured Americans Are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access to and affordability of health care.
Read More
Double Trouble: High-Deductible Plans Raise Maternity Care Costs Across 2 Calendar Years
June 27th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the June 2024 issue of The American Journal of Managed Care® about how annual high-deductible insurance plans increase maternity care costs when pregnancies cross 2 calendar years.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Support and Skepticism Emerge as Reactions to Robert F. Kennedy Jr’s HHS Nomination
November 15th 2024In the hours after President-elect Donald J. Trump tapped Robert F. Kennedy Jr to lead HHS, reactions came swiftly to the controversial pick who would have a large influence to shake up public health.
Read More